Stay updated with breaking news from Neil Solomons. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Toronto, ON (PRWEB) May 18, 2023 -- Systemic Lupus Erythematosus (SLE) clinical trials are complex and can be challenging to conduct. The use of multiple
Volker Knappertz, MD, as Executive Vice President, Research and Development, to lead the consolidated R&D function and to further enhance and advance the Aurinia pipelineScott Habig, as Chief Commercial Officer, to lead and enhance Aurinia’s commercial capabilities, replacing Max Colao, who led the formation of the...
14.07.2022 - Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) (Aurinia or the Company), a biopharmaceutical company committed to delivering therapeutics that change the course of autoimmune disease, today announced the appointment of three seasoned leaders to the ... Seite 1
Press release content from Business Wire. The AP news staff was not involved in its creation.
Use of LUPKYNIS was safe and well tolerated in patients for up to three years of treatment, with no new safety signals In AURORA 2, long-term treatment with LUPKYNIS led to a clinically relevant